Skip to Content
MilliporeSigma
Get up to 22% off for Pi Day through March 27.Save Now

MAB858-4

Anti-RSV Antibody, blend, clones 133-1H, 131-2G, and 130-12H

ascites fluid, Chemicon®, from mouse

Synonym(s):

RSV

Slide 1 of 1
Sign In to View Organizational & Contract Pricing.

Select a Size

Pricing and availability is not currently available.

About This Item

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
130-12H, monoclonal, 131-2G, monoclonal, 133-1H, monoclonal
Species reactivity:
human
Application:
ELISA, IF
Citations:
5

Key Documents

View All Documentation

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

mouse

antibody form

ascites fluid

antibody product type

primary antibodies

clone

130-12H, monoclonal, 131-2G, monoclonal, 133-1H, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

ELISA: suitable, immunofluorescence: suitable

isotype

IgG

shipped in

wet ice

Quality Level

300

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
MAB858-2MAB858-3FMAB8599
Sigma-Aldrich

Sigma-Aldrich

MAB858-4

Anti-RSV Antibody, blend, clones 133-1H, 131-2G, and 130-12H

Sigma-Aldrich

Sigma-Aldrich

MAB858-2

Anti-RSV Antibody, glycoprotein, all type A, B strains, clone 131-2G

Sigma-Aldrich

Sigma-Aldrich

MAB858-3F

Anti-RSV Antibody, nucleoprotein, clone 130-12H, FITC-conjugated

Anti-RSV Antibody, fusion protein, all type A, B strains, clone 131-2A clone 131-2A, Chemicon®, from mouse

Sigma-Aldrich

MAB8599

Anti-RSV Antibody, fusion protein, all type A, B strains, clone 131-2A

clone

130-12H, monoclonal, 133-1H, monoclonal, 131-2G, monoclonal

clone

131-2G, monoclonal

clone

130-12H, monoclonal

clone

131-2A, monoclonal

biological source

mouse

biological source

mouse

biological source

mouse

biological source

mouse

species reactivity

human

species reactivity

human

species reactivity

human

species reactivity

human

antibody form

ascites fluid

antibody form

purified immunoglobulin

antibody form

purified antibody

antibody form

purified immunoglobulin

technique(s)

ELISA: suitable, immunofluorescence: suitable

technique(s)

ELISA: suitable, immunofluorescence: suitable

technique(s)

ELISA: suitable, immunofluorescence: suitable

technique(s)

ELISA: suitable, flow cytometry: suitable, immunofluorescence: suitable, western blot: suitable

shipped in

wet ice

shipped in

wet ice

shipped in

wet ice

shipped in

wet ice

General description

RSV is a labile paramyxovirus that produces a characteristic fusion of human cells in tissue culture--the syncytial effect. Two subtypes, A and B, have been identified. Subtype B are characterized as the asymptomatic strains of the virus. The more severe clinical illnesses involve Subtype A strains.

Immunogen

A2

Application

Anti-RSV Antibody, blend, clones 133-1H, 131-2G & 130-12H is an antibody against Respiratory Syncytial Virus for use in IF, ELISA.
ELISA at 1:800+

Indirect Immunofluorescence at 1:100-200+ (fresh frozen tissue sections)

Final working dilutions must be determined by end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral

Biochem/physiol Actions

Blend of all RSV specifications of MAB858-1, 2 and 3. Recognizes the fusion, G, and nuclear protein of both A and B strains.

Physical form

Liquid ascites fluid.
Unpurified

Preparation Note

Maintain for 1 year at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Analysis Note

Control
RSV Control Slides, Catalogue Number 5012-5

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

12 - Non Combustible Liquids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Tiina Talts et al.
Microbiology spectrum, 12(4), e0306723-e0306723 (2024-02-27)
Prevention of respiratory syncytial virus (RSV) infection is now a global health priority, with a long-acting monoclonal antibody and two RSV vaccines recently licenced for clinical use. Most licenced and candidate interventions target the RSV fusion (RSV-F) protein. New interventions
John P DeVincenzo et al.
The Journal of infectious diseases, 190(5), 975-978 (2004-08-06)
Premature infants and those with chronic lung disease or congenital heart disease are at high risk of severe respiratory syncytial virus (RSV) disease. Palivizumab (Synagis), a humanized anti-RSV monoclonal antibody, has been used extensively since 1998 to prevent severe RSV
Ziyin Wang et al.
Mucosal immunology, 17(2), 272-287 (2024-02-22)
Respiratory viral infections remain a major cause of hospitalization and death worldwide. Patients with respiratory infections often lose weight. While acute weight loss is speculated to be a tolerance mechanism to limit pathogen growth, severe weight loss following infection can
Talita Bianca Gagliardi et al.
Intervirology, 60(1-2), 56-60 (2017-09-05)
Syncytia formation is the hallmark of the cytopathic effect caused by human respiratory syncytial virus (HRSV), which is the most important viral respiratory pathogen in children. This article reports methodological improvements in primary HRSV isolation and the importance of syncytia
Hayat Caidi et al.
Methods in molecular biology (Clifton, N.J.), 1442, 13-32 (2016-07-29)
Defective interfering viral particles have been reported as important determinants of the course of viral infection, and they can markedly temper the virulence of the infection. Here, we describe a simple method, based on limiting dilution, for the removal of

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service